The startup’s founding team includes CEO Richard Klausner, MD, former director of the National Cancer Institute, and President Tom Insel, MD, former director of the National Institute of Mental Health. The startup’s platform offers real-time digital biomarkers for mood and cognition, including attention and memory measures.
“To improve outcomes for people with mental disorders, we need the kind of objective measures we have for other chronic diseases like diabetes and heart disease,” Dr. Dagum said.
Foresite Capital and ARCH Venture Partners led the funding round with additional investment from Optum Ventures, Berggruen Holdings and the One Mind Brain Health Impact Fund. Mindstrong Health will use the funding to grow its clinical operations and technology team for research and development projects.
More articles on health IT:
How informatics led Dr. Don Rucker to head ONC
Health IT company CoPilot agrees to $130k settlement after delayed breach notification
DOD needs top talent to address cyberthreats, acting CIO says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
